Needham & Company LLC restated their buy rating on shares of Avadel Pharmaceuticals (NASDAQ:AVDL – Free Report) in a research note issued to investors on Monday, Benzinga reports. They currently have a $18.00 price target on the stock. A number of other equities analysts have also recently issued reports on the stock. Craig Hallum upped […]
Altium Capital Management LP acquired a new position in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 4,588,000 shares of the company’s stock, valued at approximately $1,675,000. Altium Capital Management LP owned 18.97% of GeneDx at the […]
Altium Capital Management LP decreased its holdings in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 15.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 240,000 shares of the medical research company’s stock after selling 45,000 shares during the quarter. […]
Altium Capital Management LP bought a new stake in CVRx, Inc. (NASDAQ:CVRX – Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 205,000 shares of the company’s stock, valued at approximately $1,911,000. Altium Capital Management LP owned approximately […]
Altium Capital Management LP bought a new stake in Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 35,000 shares of the company’s stock, valued at approximately $3,182,000. Reata Pharmaceuticals makes up 1.8% of Altium Capital […]